SII, the world's largest vaccine manufacturer by volume, has already received cell and vector samples from Russia's Gamaleya Centre, RDIF said. "With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun," RDIF said in a statement. Sputnik V comprises two components and the second one has proved harder to manufacture in Russia. RDIF has been looking into the possibility of mixing Sputnik with AstraZeneca and Oxford University's shots. Sputnik V vaccine has been registered in 67 countries globally with a total population of over 3.5 billion people, RDIF said in its statement.

Source: bd News24 July 13, 2021 10:18 UTC